ICML 2019 - Lugano
15th edition of the International Conference on Malignant Lymphoma
ICML 2019 - Lugano
15th edition of the International Conference on Malignant Lymphoma
interviews
The efficacy of Liquid Biopsy in the detection of blood tumor DNA
en
Prof. R. Dalla Favera
L'efficacia della Biopsia Liquida per seguire il decorso dei linfomi
it
Prof. R. Dalla Favera
State of the art of treatments in chronic lymphocytic leukemia
en
Prof. Michael Hallek
Lenalidomide/R‐CHOP fase II study results
en
Dr. G. Nowakowski
Efficacy and fields of application of the CAR-T cell therapy
en
Prof. Davide Rossi
B-cell lymphoma: the efficacy and safety of ADCT-402
en
Prof. John Radford
Large B-cell lymphoma: two studies compared
en
Prof. Anas Younes
B-cell Non-Hodgkin's Lymphoma: treatment with new antibodies
en
Dr. Michael Dickinson
Camidanlumab Tesirine in Classical Hodgkin Lymphoma
en
Dr. Graham Collins
Liquid Biopsy: the very first world workshop on this new technology
en
Prof. Davide Rossi
press conference highlights
Moving forward in chronic lymphocytic leukemia treatment
en
Prof. Michael Hallek
Moving forward in aggressive lymphoma
en
Dr. G. Nowakowski
Gene therapy for lymphomas and Liquid Biopsy
en
Prof. Davide Rossi
Questions & Answers: the difference between CAR-T and bio-specific cells
en
Questions & Answers: the CAR-T cell therapy situation in Switzerland
en
Questions & Answers: Chronic lymphocytic leukemia, treatment of asymptomatic patient
en
Questions & Answers: CLL, appropriateness of placebo in this type of study
Questions & Answers: Incidence of lenalidomide dosage on study results
en